Shares of Oddity Tech (ODD) have gained 7.2% over the past four weeks to close the last trading session at $42.4, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $66.82 indicates a potential upside of 57.6%.The mean estimate comprises 11 short-term price targets with a standard deviation of $12.63. While the lowest estimate of $46.00 indicates an 8.5% increase from the current p ...

Shares of Klarna (KLAR) have gained 8.4% over the past four weeks to close the last trading session at $30.48, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $46.06 indicates a potential upside of 51.1%.The mean estimate comprises 16 short-term price targets with a standard deviation of $3.7. While the lowest estimate of $39.00 indicates a 28% increase from the current price le ...

Nuvation Bio Inc. (NUVB) closed the last trading session at $8.99, gaining 28.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $11.25 indicates a 25.1% upside potential.The average comprises eight short-term price targets ranging from a low of $8.00 to a high of $18.00, with a standard deviation of $2.96. While the lowest estimate indicates a decline of 11% from the current price ...

WisdomTree, Inc. (WT) closed the last trading session at $11.8, gaining 7.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $15.13 indicates a 28.2% upside potential.The mean estimate comprises six short-term price targets with a standard deviation of $1.5. While the lowest estimate of $13.25 indicates a 12.3% increase from the current price level, the most optimistic analyst expe ...

Shares of Photronics (PLAB) have gained 60.2% over the past four weeks to close the last trading session at $32.96, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $43.23 indicates a potential upside of 31.2%.The average comprises three short-term price targets ranging from a low of $42.00 to a high of $45.00, with a standard deviation of $1.57. While the lowest estimate indicat ...

Shares of Figure Technology (FIGR) have gained 0.2% over the past four weeks to close the last trading session at $37.29, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $49.11 indicates a potential upside of 31.7%.The mean estimate comprises nine short-term price targets with a standard deviation of $6.17. While the lowest estimate of $40.00 indicates a 7.3% increase from the c ...

Shares of VAREX IMAGING (VREX) have gained 3.2% over the past four weeks to close the last trading session at $11.8, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $15.33 indicates a potential upside of 29.9%.The mean estimate comprises three short-term price targets with a standard deviation of $3.06. While the lowest estimate of $12.00 indicates a 1.7% increase from the curre ...

华尔街分析师目标价与共识 - 达科电子股票近期收于18.77美元，过去四周微涨0.1% [1] - 华尔街分析师设定的平均目标价为23.67美元，暗示有26.1%的上涨潜力 [1] - 三个短期目标价范围从16.00美元到31.00美元，标准差为7.51美元，最低目标价意味着下跌14.8%，最乐观目标价则意味着上涨65.2% [2] 目标价的局限性及分析师行为 - 共识目标价虽是投资者追捧的指标，但仅凭此做出投资决策可能并不明智，因为分析师设定目标价的能力和公正性长期受到质疑 [3] - 全球多所大学的研究表明，目标价是众多股票信息中误导投资者远多于指导投资者的信息之一，实证研究显示，无论共识程度如何，分析师设定的目标价很少能准确指示股价的实际走向 [7] - 华尔街分析师虽对公司基本面及其业务对经济和行业问题的敏感性有深入了解，但许多人倾向于设定过于乐观的目标价，这通常是为了鼓动市场对其公司已有业务关系或希望建立关系的公司股票产生兴趣，即覆盖股票的公司业务激励常导致分析师设定虚高的目标价 [8] 盈利预期修正的积极信号 - 分析师对公司盈利前景日益乐观，这可能是预期股价上涨的合理理由，因为实证研究显示盈利预期修正趋势与短期股价变动之间存在强相关性 [11] - 过去30天内，本年度Zacks共识预期已上调4.6%，因为有一项预期上调，而没有负面修正 [12] - 达科电子目前拥有Zacks排名第二级（买入），这意味着其在基于盈利预期相关四因素进行排名的4000多只股票中位列前20%，鉴于其令人印象深刻的外部审计记录，这是该股近期潜在上涨更具结论性的指标 [13] 投资参考框架 - 尽管共识目标价可能不是达科电子能上涨多少的可靠指标，但其暗示的价格变动方向似乎是一个很好的指引 [14] - 目标价高度集中（以低标准差表示）表明分析师对股价变动的方向和幅度有高度共识，这虽不必然意味着股价会达到平均目标价，但可以作为一个良好的起点，以便进行旨在识别潜在基本面驱动力的进一步研究 [9] - 投资者不应完全忽视目标价，但仅基于此做出投资决策可能导致令人失望的投资回报率，因此应始终以高度怀疑的态度对待目标价 [10]

Compass Therapeutics, Inc. (CMPX) closed the last trading session at $5.39, gaining 13% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $12.62 indicates a 134.1% upside potential.The mean estimate comprises 13 short-term price targets with a standard deviation of $6.67. While the lowest estimate of $8.00 indicates a 48.4% increase from the current price level, the most optimistic a ...

股价表现与华尔街目标价 - Braze公司股票在最近一个交易日收于34.93美元 在过去四周上涨了23.8% [1] - 华尔街分析师设定的平均目标价为46.63美元 意味着较当前股价有33.5%的上行潜力 [1] - 19个短期目标价范围从38.00美元到68.00美元 最低目标价意味着8.8%的上涨 最乐观目标价则意味着94.7%的上涨 [2] 分析师目标价的解读与局限性 - 分析师设定的目标价的标准差为6.53美元 标准差越小表明分析师之间的共识度越高 [2][9] - 尽管分析师对公司基本面和业务敏感性有深入了解 但他们常因公司业务激励为存在或寻求合作关系的公司设定过于乐观的目标价 [8] - 实证研究表明 分析师设定的目标价无论共识度如何 很少能准确指示股票价格的实际走向 投资者不应完全依赖目标价做投资决策 [7][10] 盈利预期修正与评级 - 分析师对公司盈利前景的乐观情绪日益增强 表现在他们一致上调每股收益预期 [4][11] - 过去30天内 Zacks对本年度的共识预期上调了0.2% 因为有一项预期上调且没有负面修正 [12] - Braze目前拥有Zacks Rank 2评级 这意味着它在基于盈利预期相关四因素进行排名的4000多只股票中位列前20% 这为近期潜在上行提供了更具结论性的指标 [13] 综合投资观点 - 尽管共识目标价本身可能不是衡量涨幅的可靠指标 但其暗示的价格变动方向似乎是一个良好的指引 [14] - 盈利预期修正的趋势与短期股价变动之间存在强相关性 这是预期股价上行的合理理由 [11] - 分析师目标价的高度集中 可以作为深入研究以识别潜在基本面驱动力的良好起点 [9]